North Dakota § 54-52.1-17 Uniform group insurance program - Collaborative drug therapy program - Funding

North Dakota Statutes

§ 54-52.1-17 — Uniform group insurance program - Collaborative drug therapy program - Funding

North Dakota § 54-52.1-17

Title 54State Government

Ch. 54-52.1Uniform Group Insurance Program

This text of North Dakota § 54-52.1-17 (Uniform group insurance program - Collaborative drug therapy program - Funding) is published on Counsel Stack Legal Research, covering North Dakota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

N.D. Cent. Code § 54-52.1-17 (2026).

Text

Funding.

1.The board shall establish a collaborative drug therapy program that is to be available to individuals in the medical and hospital benefits coverage group. The purpose of the collaborative drug therapy program is to improve the health of individuals with diabetes and to manage health care expenditures.

2.The board shall involve physicians, pharmacists, and certified diabetes educators to coordinate health care for covered individuals with diabetes in order to improve health outcomes and reduce spending on diabetes care. Under the program, pharmacists and certified diabetes educators may be reimbursed for providing face-to-face collaborative drug therapy services to covered individuals with diabetes. To encourage enrollment in the plan, the board shall provide incentives to cov

Free access — add to your briefcase to read the full text and ask questions with AI

Funding.
1. The board shall establish a collaborative drug therapy program that is to be available
to individuals in the medical and hospital benefits coverage group. The purpose of the
collaborative drug therapy program is to improve the health of individuals with diabetes
and to manage health care expenditures.
2. The board shall involve physicians, pharmacists, and certified diabetes educators to
coordinate health care for covered individuals with diabetes in order to improve health

outcomes and reduce spending on diabetes care. Under the program, pharmacists
and certified diabetes educators may be reimbursed for providing face-to-face
collaborative drug therapy services to covered individuals with diabetes. To encourage
enrollment in the plan, the board shall provide incentives to covered individuals who
have diabetes which may include waived or reduced copayment for diabetes treatment
drugs and supplies.
3. The North Dakota pharmacists association or a specified delegate shall implement a
formalized diabetes management program with the approval of the prescriptive
practices committee established in section 43-15-31.4, which must serve to
standardize diabetes care and improve patient outcomes. This program must facilitate
enrollment procedures, provide standards of diabetes care, enable consistent
documentation of clinical and economic outcomes, and structure an outcomes
reporting system.
4. The board shall fund the program from any available funds in the uniform group
insurance program and if necessary the fund may add up to a two dollar per month
charge on the policy premium for medical and hospital benefits coverage. A state
agency shall pay any additional premium from the agency's existing appropriation.